Author:
Penninger J. M.,Bachmaier K.
Publisher
Springer Berlin Heidelberg
Reference45 articles.
1. Anderson JL, Muhlestein JB, Carlquist J, Allen A, Trehan S, Nielson C, Hall S, Brady J, Egger M, Horne B, Lim T (l999). Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study [see comments]. Circulation 99,1540–1547
2. Bachmaier K, Le J, Penninger JM (2000) “Catching heart disease”: antigenic mimicry and bacterial infections [letter]. Nat Med 6, 841–842
3. Bachmaier K, Neu N, De la Maza LM, Pal S, Hessel A, Penninger JM (1999) Chlamydia infections and heart disease linked through antigenic mimicry [see comments]. Science 283, 1335–1339
4. Bachmaier K, Neu N, Pummerer C, Duncan GS, Mak TW, Matsuyama T, Penninger JM (1997) iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation. 96, 585–591
5. Bachmaier K, Neu N, Yeung RSM, Mak TW, Liu P, Penninger JM (1999) Generation of humanized mice susceptible to peptide-induced inflammatory heart disease. Circulation 99, 1885–1891